Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
暂无分享,去创建一个
D. Hicklin | R. Kerbel | A. Davidoff | S. Man | G. Francia | G. Bocci | P. Thorpe | J. Ebos | S. K. Green | U. Emmenegger | Li Ma | J. D. du Manoir | J. Huber | Adina Weinerman | James Huber